NRXS
HEALTHCARENeuraxis Inc
$8.81+0.12 (+1.38%)PRE
Live · AMEX · May 9, Close
AI Insight
What's Moving NRXS Today?
No stock-specific AI insight has been generated for NRXS yet. Check back soon — insights are generated from recent news analysis.
52-Week Range
$2.00$9.33
$8.81
Fundamentals
Market Cap$101M
P/E Ratio—
EPS$-0.95
Dividend Yield—
Dividend / Share—
ROE-2.9%
Profit Margin-2.2%
Debt / Equity—
Trading
Volume302K
Avg Volume (10D)—
Shares Outstanding11.5M
NRXS News
20 articles- NeurAxis to Host First Quarter 2026 Results and Business Update Call on Tuesday, May 12, 2026Yahoo Finance·May 5, 2026
- The Zacks Analyst Blog Highlights Alphabet, Walmart, Micron Technology and NeurAxisYahoo Finance·May 5, 2026
- Top Stock Reports for Alphabet, Walmart & MicronYahoo Finance·May 4, 2026
- NeurAxis Expands Payer Coverage with Four New Medical PoliciesYahoo Finance·Apr 22, 2026
- NeurAxis, Inc. Announces Preferred Stock DividendYahoo Finance·Apr 10, 2026
- NeurAxis Stock Gains Post Q4 Earnings on Strong Revenue GrowthYahoo Finance·Mar 24, 2026
- Neuraxis Inc (NRXS) Q4 2025 Earnings Call Highlights: Revenue Growth Amidst Operational ChallengesYahoo Finance·Mar 19, 2026
- NeurAxis, Inc. Q4 2025 Earnings Call SummaryMoby·Mar 19, 2026
- NeurAxis Reports Strong Fourth Quarter and Full Year 2025 Financial ResultsYahoo Finance·Mar 19, 2026
- NeurAxis to Host Fourth Quarter and Full Year 2025 Results and Business Update Call on Thursday, March 19, 2026Yahoo Finance·Mar 12, 2026
- NeurAxis Achieves Major Milestone with AMA Category I CPT® Code Now in Effect, Establishing a Permanent Reimbursement PathwayYahoo Finance·Jan 8, 2026
- Top Stock Reports for Meta, Bank of America & Procter & GambleYahoo Finance·Jan 5, 2026
- NeurAxis Achieves Medical Coverage Policy Milestone, Expanding Access to Approximately 45 million additional Covered LivesYahoo Finance·Dec 19, 2025
- NeurAxis Secures Veterans Affairs Federal Supply Schedule Contract, Broadening Access to More Patients with Functional Abdominal PainYahoo Finance·Dec 1, 2025
- NRXS Stock Declines Post Q3 Earnings Despite Continued Revenue GrowthYahoo Finance·Nov 17, 2025
- NeurAxis Announces New Medical Policy Coverage in Michigan, Adding 566,000 Covered LivesYahoo Finance·Nov 12, 2025
- NeurAxis Reports Strong Third Quarter 2025 Financial Results Driven by a 22% Growth in RevenuesYahoo Finance·Nov 11, 2025
- NeurAxis to Host Third Quarter 2025 Results and Business Update Call on Tuesday, November 11, 2025Yahoo Finance·Nov 4, 2025
- NeurAxis Awarded First Ever FDA Clearance for the Treatment of Pain in Functional Dyspepsia (FD) with associated Nausea Symptoms in the Adult Patient PopulationYahoo Finance·Oct 24, 2025
- NeurAxis to Participate in the Lytham Partners Fall 2025 Investor Conference on September 30, 2025Yahoo Finance·Sep 18, 2025
All 20 articles loaded
Price Data
Open$8.76
Previous Close$8.69
Day High$9.04
Day Low$8.30
52 Week High$9.33
52 Week Low$2.00
52-Week Range
$2.00$9.33
$8.81
Fundamentals
Market Cap$101M
P/E Ratio—
EPS$-0.95
Dividend Yield—
Dividend / Share—
ROE-2.9%
Profit Margin-2.2%
Debt / Equity—
Trading
Volume302K
Avg Volume (10D)—
Shares Outstanding11.5M
About Neuraxis Inc
NeurAxis, Inc. is a neuromodulation therapy device company in the United States. The company is headquartered in Versailles, Indiana.
HEALTHCAREBIOTECHNOLOGY
Company Details
Security TypeStock
ExchangeAMEX
CurrencyUSD
Round Lot—
SICBIOTECHNOLOGY
CIK—
Composite FIGI—
Share Class FIGI—